Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Bancroft

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
JAMA Network Open|April 29, 2022
Meningococcal Vaccination Rates Among People With a New Diagnosis of HIV Infection in the USParinaz K Ghaswalla, Gary S Marshall, Lindsay G S Bengtson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2021
Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United StatesGary S Marshall, Parinaz K Ghaswalla, Lindsay G S Bengtson, et al.
Influenza and Other Respiratory Viruses|September 13, 2022
A novel household-based patient outreach pilot program to boost late-season influenza vaccination rates during the COVID-19 pandemicLloyd Fisher, Matthew M Loiacono, Nick Payne, et al.
Plos One|September 27, 2021
Development and validation of a one year predictive model for secondary fractures in osteoporosisSetareh A Williams, Susan L Greenspan, Tim Bancroft, et al.
JAMA Network Open|January 14, 2026
Lyme Disease and Health Care CostsHolly Yu, Rebecca M Fee, Brian T Campfield, et al.
Journal of Comparative Effectiveness Research|December 15, 2023
Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory settingAlexander Russell-Smith, Louise Murphy, Amy Nguyen, et al.
Vaccine|January 26, 2022
Corrigendum to 'Meningococcal vaccination in patients with newly diagnosed asplenia in the United States' [Vaccine 39 (2021) 272-281]Parinaz K Ghaswalla, Lindsay G S Bengtson, Gary S Marshall, et al.
Journal of Comparative Effectiveness Research|December 3, 2025
Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladderHolly E Richter, Benjamin Chastek, Adam Carrera, et al.
Vaccine|December 14, 2020
Meningococcal vaccination in patients with newly diagnosed asplenia in the United StatesParinaz K Ghaswalla, Lindsay G S Bengtson, Gary S Marshall, et al.
Pulmonary Circulation|November 14, 2018
Validation of a claims-based algorithm to identify patients with chronic thromboembolic pulmonary hypertension using electronic health record dataSimon Teal, William R Auger, Rodney J Hughes, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
JAMA Network Open|April 29, 2022
Meningococcal Vaccination Rates Among People With a New Diagnosis of HIV Infection in the USParinaz K Ghaswalla, Gary S Marshall, Lindsay G S Bengtson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2021
Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United StatesGary S Marshall, Parinaz K Ghaswalla, Lindsay G S Bengtson, et al.
Influenza and Other Respiratory Viruses|September 13, 2022
A novel household-based patient outreach pilot program to boost late-season influenza vaccination rates during the COVID-19 pandemicLloyd Fisher, Matthew M Loiacono, Nick Payne, et al.
Plos One|September 27, 2021
Development and validation of a one year predictive model for secondary fractures in osteoporosisSetareh A Williams, Susan L Greenspan, Tim Bancroft, et al.
JAMA Network Open|January 14, 2026
Lyme Disease and Health Care CostsHolly Yu, Rebecca M Fee, Brian T Campfield, et al.
Journal of Comparative Effectiveness Research|December 15, 2023
Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory settingAlexander Russell-Smith, Louise Murphy, Amy Nguyen, et al.
Vaccine|January 26, 2022
Corrigendum to 'Meningococcal vaccination in patients with newly diagnosed asplenia in the United States' [Vaccine 39 (2021) 272-281]Parinaz K Ghaswalla, Lindsay G S Bengtson, Gary S Marshall, et al.
Journal of Comparative Effectiveness Research|December 3, 2025
Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladderHolly E Richter, Benjamin Chastek, Adam Carrera, et al.
Vaccine|December 14, 2020
Meningococcal vaccination in patients with newly diagnosed asplenia in the United StatesParinaz K Ghaswalla, Lindsay G S Bengtson, Gary S Marshall, et al.
Pulmonary Circulation|November 14, 2018
Validation of a claims-based algorithm to identify patients with chronic thromboembolic pulmonary hypertension using electronic health record dataSimon Teal, William R Auger, Rodney J Hughes, et al.
Pageof 5